Patents by Inventor Shunichiro UESUGI
Shunichiro UESUGI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230287009Abstract: Provided is a novel compound that has an excellent ?-lactamase inhibitory effect. More specifically, provided is a compound represented by formula (1a), (1b) or (11) having an excellent ?-lactamase inhibitory effect or a pharmaceutically acceptable salt thereof. By using this compound either in combination with a ?-lactam drug or alone, a useful preventive or therapeutic agent for bacterial infections is provided. Also provided are useful preventive or therapeutic agents for treating various diseases with the combined use of the aforesaid compound and ?-lactam drugs.Type: ApplicationFiled: April 28, 2023Publication date: September 14, 2023Applicants: Sumitomo Pharma Co., Ltd., THE KITASATO INSTITUTEInventors: Toshio KANAI, Sachiko KOIKE, Takayuki FUKAYA, Shunichiro UESUGI, Shingo MIZUSHIMA, Hitoshi SUDA, Yuki MIZUKAMI, Yohei IKUMA, Toshiaki SUNAZUKA, Yoshihiko NOGUCHI
-
Patent number: 11702431Abstract: Provided is a novel compound that has an excellent ?-lactamase inhibitory effect. More specifically, provided is a compound represented by formula (1a), (1b) or (11) having an excellent ?-lactamase inhibitory effect or a pharmaceutically acceptable salt thereof. By using this compound either in combination with a ?-lactam drug or alone, a useful preventive or therapeutic agent for bacterial infections is provided. Also provided are useful preventive or therapeutic agents for treating various diseases with the combined use of the aforesaid compound and ?-lactam drugs.Type: GrantFiled: April 26, 2019Date of Patent: July 18, 2023Assignees: Sumitomo Pharma Co., Ltd., THE KITASATO INSTITUTEInventors: Toshio Kanai, Sachiko Koike, Takayuki Fukaya, Shunichiro Uesugi, Shingo Mizushima, Hitoshi Suda, Yuki Mizukami, Yohei Ikuma, Toshiaki Sunazuka, Yoshihiko Noguchi
-
Publication number: 20230088694Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.Type: ApplicationFiled: November 26, 2020Publication date: March 23, 2023Applicant: Sumitomo Dainippon Pharma Co., Ltd.Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
-
Publication number: 20230038124Abstract: The present invention provides a novel compound having an excellent ?-lactamase inhibitory effect. The present invention provides: a compound which has an excellent ?-lactamase inhibitory effect, and is represented by formula (1a), (1b) or (11); or a pharmaceutically acceptable salt thereof. This compound provides a prophylactic or therapeutic agent effective for bacterial infections when used in combination with ?-lactam-based drugs or used as a single agent. The present invention also provides a prophylactic or therapeutic agent effective for treating various diseases, by being used in combination with ?-lactam-based drugs.Type: ApplicationFiled: October 23, 2020Publication date: February 9, 2023Applicant: Sumitomo Pharma Co., Ltd.Inventors: Sachiko KOIKE, Yohei IKUMA, Takayuki FUKAYA, Shunichiro UESUGI
-
Patent number: 11352357Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.Type: GrantFiled: November 15, 2021Date of Patent: June 7, 2022Assignee: Sumitomo Dainippon Pharma Co., Ltd.Inventors: Eiji Ideue, Masafumi Komiya, Shoukou Lee, Shunichiro Uesugi, Yuta Funakoshi
-
Publication number: 20220081441Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.Type: ApplicationFiled: November 15, 2021Publication date: March 17, 2022Applicant: Sumitomo Dainippon Pharma Co., Ltd.Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
-
Patent number: 11066425Abstract: Provided is a novel compound that has an excellent ?-lactamase inhibitory effect. More specifically, provided is a compound represented by formula (1a), (1b) or (11) having an excellent ?-lactamase inhibitory effect or a pharmaceutically acceptable salt thereof. By using this compound either in combination with a ?-lactam drug or alone, a useful preventive or therapeutic agent for bacterial infections is provided. Also provided are useful preventive or therapeutic agents for treating various diseases with the combined use of the aforesaid compound and ?-lactam drugs.Type: GrantFiled: December 29, 2020Date of Patent: July 20, 2021Assignees: SUMITOMO DAINIPPON PHARMA CO., LTD., THE KITASATO INSTITUTEInventors: Toshio Kanai, Sachiko Koike, Takayuki Fukaya, Shunichiro Uesugi, Shingo Mizushima, Hitoshi Suda, Yuki Mizukami, Yohei Ikuma, Toshiaki Sunazuka, Yoshihiko Noguchi
-
Publication number: 20210147448Abstract: Provided is a novel compound that has an excellent ?-lactamase inhibitory effect. More specifically, provided is a compound represented by formula (1a), (1b) or (11) having an excellent ?-lactamase inhibitory effect or a pharmaceutically acceptable salt thereof. By using this compound either in combination with a ?-lactam drug or alone, a useful preventive or therapeutic agent for bacterial infections is provided. Also provided are useful preventive or therapeutic agents for treating various diseases with the combined use of the aforesaid compound and ?-lactam drugs.Type: ApplicationFiled: April 26, 2019Publication date: May 20, 2021Applicants: SUMITOMO DAINIPPON PHARMA CO., LTD., THE KITASATO INSTITUTEInventors: Toshio KANAI, Sachiko KOIKE, Takayuki FUKAYA, Shunichiro UESUGI, Shingo MIZUSHIMA, Hitoshi SUDA, Yuki MIZUKAMI, Yohei IKUMA, Toshiaki SUNAZUKA, Yoshihiko NOGUCHI